To Clot Or Not To Clot… Emergency Care for Coagulation Disorders/Conditions Rebecca Goldsmith Pediatric Thrombosis/Hemophilia Nurse McMaster Children’s.

Slides:



Advertisements
Similar presentations
Chapter 19 Hematologic Products.
Advertisements

Venous Thrombo-embolism In Pregnancy
Evidence-Based Management of Anticoagulant Therapy
LHD Logo Venous Thromboembolism Reducing the Risk DATE.
Deep venous thrombosis and pulmonary embolism in pregnancy Petr Krepelka, 2013.
Chapter Six Venous Disease Coalition Acute Management of VTE VTE Toolkit.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Deep Vein Thrombosis (DVT)
Medications that impact bleeding By Nino Lalaiants Inesa Legrian NYCCT 2012.
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
Deep vein thrombosis David Hughes. Pathophysiology normal deep pelvic/leg veins thrombus (red cells, fibrin) around valves propagation Virchow’s triad.
PTP 546 Module 6 Cardiovascular Pharmacology: Part II Jayne Hansche Lobert, MS, RN, ACNS-BC, NP 1Lobert.
HEPARIN INDUCED THROMBOCYTOPENIA GALILA ZAHER MBB ch, dip C Path, MRC Path.
Anticoagulation in the Acute Care Population Aimee Ring PT, DPT, GCS.
Principles of anticoagulant tratment
CHEST-2012: High Points and Pearls Alan Brush, MD, FACP Chief, Anticoagulation Management Service Harvard Vanguard Medical Associates.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
Pulmonary Embolism Jeannette Corona. Title: Alteplase Treatment of Acute Pulmonary Embolism in the Intensive Care Unit Authors: Pamela L. Smithburger,
What is it? A deep vein thrombosis is a condition where the blood clots in a distal, deep vein A blood clot is considered a thrombosis as long as it is.
DR FAROOQ AHMAD RANA ASSISTANT PROFESSOR SURGERY
ANTICOAGULANT BY :DR ISRAA OMAR.
DR. ahmed Abanamy hospital DOCTOR Nazih Mohammed Alothman Vascular Surgeon.
What You Need to Know about Blood Clots. What You Need to Know About Blood Clots or Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
WARFARIN AN OVERVIEW.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
ANTICOAGULANT, THROMBOLYTICS & ANTIPLATELET DRUGS.
Warfarin therapy in intravenous drug abusers Dewsbury and District Hospital Anticoagulant Service.
Total Joint Replacement
Study Guide Guide for Patients Undergoing Anticoagulant Therapy.
Venous Thromboembolism
Cancer-Associated Thrombosis
Anticoagulants 1. Parenteral Anticoagulants e.g. heparin
Case Report Pneumology Dr. David Tran A&E, FVHospital Medical meeting September 28 th, 2011.
P ULMONARY E MBOLISM. W HAT IS A PULMONARY E MBOLISM ? A Pulmonary Embolism occurs when major blood vessels (arteries) in the lungs become blocked. Usually.
Shortness of breath By: Tina Tarazi. Patient is a 49 year old F with PMH of NSCLC s/p chemotherapy and radiation and right frontal lobe resection in 12/2013.
CARDIOVASCULAR MODULE: DEEP VENOUS THROMBOSIS THROMBOPHLEBITIS Adult Medical-Surgical Nursing.
Thrombophilia National Haemophilia Director
Acute venous or arterial thrombosis Acute venous or arterial thrombosis Is there clinical concern for an anatomic compressive syndrome or occlusive iliofemoral.
Drugs Used to Treat Thromboembolic Disorders Chapter 27 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
IBSc: Question 9 By Alan McLeod. Getting the best marks Read the whole question – a latter section may give you a clue about an earlier one. To see how.
Core Measures 2014 Revised 11/30/13.
Case Discussion Dr. Raid Jastania. A 65-year-old man presented to the emergency room with a recent (4-hour) history of severe chest pain radiating to.
Thrombophlebitis Continued Nick Myhre. Signs and Symptoms Swelling, Redness, and Pain associated with the clot.
Drugs Susan Louw Haematology Registrar. 4 Questions to ask: Can I stop? (What is the risk of thrombosis?) Should I stop? (What is the risk of bleeding?)
Agents Affecting Blood Clotting
Deep vein thrombosis and pulmonary embolism.
Deep Vein Thrombosis (DVT)
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
DVT cases.  Heparin, low molecular weight heparin, or fondaparinux are usually continued for at least five days, along with another medication called.
Anticoagulants Course: Pharmacology I Course Code: PHR 213 Course Instructor: Sabiha Chowdhury Lecturer Department of Pharmacy BRAC University.
Course Lecturer: Imon Rahman
One of the main causes of DVT is inactivity! When a person is inactive, your blood normally collects in the lower part of your body. (in your legs) This.
Anticoagulant Therapy
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
Outpatient DVT assessment & treatment Daniel Gilada.
Chapter 23 Thrombo-Embolic diseases
Bleeding disorders Deficiency of any of the clotting factors leads to excessive bleeding Most common and important bleeding disorders are due Vitamin K.
Evidence-Based Management of Anticoagulant Therapy
Prothrombin complex concentrate
Deep Vein Thrombosis & Pulmonary Embolism
By: Dr. Nalaka Gunawansa
Clinical Knowledge Summaries CKS Pulmonary embolism (PE)
Anticoagulants and Antiplatelets
Anticoagulants in the Treatment of Venous Thromboembolism
The normal haemostasis process involves three stages: 1
ANTICOAGULANTS Dr. A. Shyam Sundar. M.Pharm., Ph.D,
The role of anticoagulation in venous shunts
Anticoagulants.
Presentation transcript:

To Clot Or Not To Clot… Emergency Care for Coagulation Disorders/Conditions Rebecca Goldsmith Pediatric Thrombosis/Hemophilia Nurse McMaster Children’s Hospital Current Concept in Pediatrics October 16 th, 2009

Objectives  Virchow’s Triad  Reasons for referrals  Line related DVTs  Anticoagulation of DVTs  Case study – keypad question  Clinic information  Questions

Virchow’s Triad Blood flow (stasis) Vessel Blood Wall Components

Reasons for Referrals  Prothrombotic workup  Deep Vein Thrombosis (DVT)  Pulmonary Embolism (PE)  Stroke  Fracture prophylaxis  Arterial thrombosis

Reasons for Anticoagulation  DVT  Cardiac prophylaxis(BT shunt, Fontan procedure, Norwood procedure)  Fracture prophylaxis  Arterial clot  Hereditary prothrombotic states  Stroke (pediatric pts. cerebral sinovenous thrombosis, CSVT) however, there is not a lot of evidence to support this

Line related DVTs  Clinical observation CVL dysfunction Limb or facial swelling distal to a CVL insertion site Superficial new collateral vein development Pain, swelling, or redness in limb Abdominal pain +/- fever without other explanation

 Confirmation of limb DVT can be made with - Compression Doppler U/S - Venogram - MRV

Treatment Options Tissue Plasminogen Activator has become the most commonly used thrombolytic agent in the pediatric population (TPA), in hospital. Converts endogenous plasminogen to plasmin the most useful assay is a fibrinogen level Low Molecular Weight Heparin (LMWH) LMWH has specific anti- factor Xa activity and reduced anti- factor IIa activity Xa therapeutic level is U/ml in a sample taken 4-6 hrs post sc inj. Dosing of LMWH starts at 1mg/kg bid Warfarin is a Vitamin K antagonist and functions by reducing plasma concentration of vitamin K- dependent factors (II, VII, IX, X) Warfarin loading dose: 0.2mg/kg as a single night time dose. Dosage adjustments to be made until INR is

LMWH AdvantagesDisadvantage * Subcutaneous injections daily or twice daily minimal monitoring required reduced risk of interaction with other medication or diet reduced risk of heparin induced thrombocytopenia (HIT) probable reduced risk of osteoporosis in long-term

Warfarin Therapy Advantages Taken per os no injections Disadvantages *Therapeutic range of INR must be in place at least two consecutive days prior to removing LMWH * many drug interactions (ex. Antibiotics) * interacts with diet high in Vitamin K enriched foods *reduced bone density in pts taking warfarin for more than one year

Case Study Question- A 17 yr old female presents in ER.  She appears anxious, sweating.  She has a rapid HR and low BP.  c/o sharp chest pain and shortness of breath. She admits to taking oral contraceptive pills for three months.

You suspect which of the following? 1. Myocardial infarct 2. Pulmonary embolism 3. Pregnancy 4. Panic Attack

Pulmonary embolism  Confirm diagnosis with ventilation-perfusion scan

Clinic Information Pediatric Thrombosis Clinic Hamilton Health Sciences 1200 Main St West Hamilton ex 75970

References Monagle, P., Chan, A.K.C., deVeber, G, Massicotte, M.P. (2006).Pediatric Thromboemolism and Stroke (3 rd ed.). Hamilton, ON: B.C. Decker Inc. Resources: Machealth.ca Thrombosis Interest Group of Canada